SELECT FROM MENU

Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immuno-therapies

Antibody Drug Conjugates

Antibody-Drug Conjugates

2025 Approvals & Highlights

2025 Approvals & Highlights

2025 Year in Review DRUGGABLE SINCE 2025: New Approvals and Emerging Options Solange Peters The Year of SCLC: From hope to practice Charles Rudin Highlights in Targeted Therapies and ADCs Martin Reck  18 December 2025 } 1 h 49 min Get Certificate This session was...
Small Cell Lung Cancer

Small Cell Lung Cancer

Small Cell Lung Cancer THE EMERGING ROLE OF DLL3 T-CELL ENGAGERS IN SCLC Giannis Mountzios EXPANDING OUR OPTIONS WITH IO COMBINATION THERAPIES IN LS- AND ES-SCLC Jacob Sands Open Discussion, Viewer Questions & Patient Cases Solange Peters  17 June 2025 } 1 h 35...

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates